Why 2017 Was a Year to Remember for Johnson & Johnson
With less than two weeks remaining in 2017, Johnson & Johnson (NYSE: JNJ) is on track to have its second-best year of the century so far for stock performance. The healthcare giant's share price is up close to 24% year to date. J&J stock is at an all-time high. Johnson & Johnson shareholders have even more to like about 2017, with the dividend payout also at an all-time high.
Why has 2017 been such a year to remember for Johnson & Johnson. Here are the top three reasons.
Image source: Getty Images.
Source: Fool.com
Johnson & Johnson Aktie
143,98 €
-0,44 %
Mit 41 Buy-Einschätzungen und nur 1 Sell-Einschätzungen ist Johnson & Johnson einer der Lieblinge unserere Community.
Das Kursziel von 196 € für Johnson & Johnson weist auf eine Steigerung von über 20% gegenüber dem aktuellen Kurs von 143.98 € hin.
